Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
OSCOTEC
★★★★
OSCOTEC Signs Global License Agreement for SYK Inhibitor Cebidoplenib - $25M Upfront and Up to $640M Milestones, Enhancing Shareholder Value
06/01/2026, 04:08 PM
OWNR
OSCOTEC
★
Samsung Asset Management reduces OSCOTEC stake from 5.14% to 4.11%... maintains simple investment purpose
05/29/2026, 04:05 PM
EXCH
OSCOTEC
★
IND Approval for Phase 1 Bioequivalence Study of SKI-O-703 (Formulation Change)
05/22/2026, 04:51 PM
OWNR
OSCOTEC
★
Tiger Asset Management increases stake in OSCOTEC to 5.09% (simple investment purpose)
05/22/2026, 02:45 PM
PERI
OSCOTEC
★
OSCOTEC Q1 2026: Consolidated Loss but Parent Turns Profitable, Sanofi Deal Positive
05/14/2026, 04:36 PM
EXCH
OSCOTEC
★
Holding of IR Meeting
05/14/2026, 03:54 PM
EXCH
OSCOTEC
★★★
OscoTech to Receive $5.1M Milestone from Yuhan's European Commercialization of EGFR Cancer Drug
05/14/2026, 03:08 PM
EXCH
OSCOTEC
★
Notice of IR Event Hosted by IBK Investment & Securities
05/07/2026, 03:27 PM